Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia

Internal Medicine

Volumn 44, Issue 8, 2005, Pages 775-776

  Asou, Norio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; Arsenic trioxide; PML RAR

Indexed keywords

ARSENIC TRIOXIDE;

BLOOD TOXICITY; CANCER RELAPSE; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG ERUPTION; EDITORIAL; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOCYTOSIS; LIVER TOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIMARY HEALTH CARE; PROMYELOCYTIC LEUKEMIA; QT PROLONGATION; SUDDEN DEATH; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; ARSENICALS; HUMANS; JAPAN; LEUKEMIA, PROMYELOCYTIC, ACUTE; OXIDES; RECURRENCE;

EID: 24644459417     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.775     Document Type: Editorial

References (8)

1. Ohno R, Asou N, Ohnishi K. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia 17: 1454-1463, 2003.
2. Asou N, Adachi K, Tamura J, et al. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. J Clin Oncol 16: 78-85, 1998.
3. Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide (As203) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89: 3354-3360, 1997.
4. Niu C, Yan H, Yu T, et al. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 94: 3315-3324, 1999.
5. Soignet SL, Maslak P, Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339: 1341-1348, 1998.
6. Soignet SL, Frankel SR, Douer D, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 19: 3852-3860, 2001.
7. Ohnishi K, Yoshida H, Shigeno K, et al. Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Leukemia 16: 617-622, 2002.
8. Shinjo K, Takeshita A, Sahara N, et al. Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatment. Intern Med 44: 818-824, 2005.